Found 9 results
Author Title [ Type(Desc)] Year
Filters: Author is Koup, R  [Clear All Filters]
Conference Paper
J. Lathey, Gregory, S., Zhang, Y., Horton, H., Koup, R., Cox, J., Gerrari, G., Baller, R., D’Souza, P., Oden, N., and Lopaczynski, W., Untitled, in AIDS Vaccine 04: Global Commitment, Lausanne, Switzerland, 2004.
Journal Article
J. Ledgerwood, DeZure, A., Stanley, D., Novik, L., Enama, M., Berkowitz, N., Hu, Z., Joshi, G., Ploquin, A., Sitar, S., Gordon, I., Plummer, S., Holman, L., ,, Mascola, J., Koup, R., Sullivan, N., and Graham, B., Chimpanzee Adenovirus Vector Ebola Vaccine - Preliminary Report, N Engl J Med, 2014.
J. E. Ledgerwood, Bellamy, A. R., Belshe, R., Bernstein, D. I., Edupuganti, S., Patel, S. M., Renehan, P., Zajdowicz, T., Schwartz, R., Koup, R., Bailer, R. T., Yamshchikov, G. V., Enama, M. E., Sarwar, U., Larkin, B., and Graham, B. S., DNA Priming for Seasonal Influenza Vaccine: a Phase 1b Double-Blind Randomized Clinical Trial, PLoS One, vol. 10, no. 5, p. e0125914, 2015.
M. Crank, Gordon, I., Yamshchikov, G., Sitar, S., Hu, Z., Enama, M., Holman, L., Bailer, R., Pearce, M., Koup, R., Mascola, J., Nabel, G., Tumpey, T., Schwartz, R., Graham, B., and Ledgerwood, J., Phase 1 Study of Pandemic H1 DNA Vaccine in Healthy Adults, PLoS One, vol. 10, no. 4, p. e0123969, 2015.
U. Sarwar, Costner, P., Enama, M., Berkowitz, N., Hu, Z., Hendel, C., Sitar, S., Plummer, S., Mulangu, S., Bailer, R., Koup, R., Mascola, J., Nabel, G., Sullivan, N., Graham, B., and Ledgerwood, J. E., Safety and Immunogenicity of DNA Vaccines Encoding Ebolavirus and Marburgvirus Wild-Type Glycoproteins in a Phase I Clinical Trial, J Infect Dis, vol. 211, no. 4, pp. 549-557, 2015.
H. Kibuuka, Berkowitz, N., Millard, M., Enama, M., Tindikahwa, A., Sekiziyivu, A., Costner, P., Sitar, S., Glover, D., Hu, Z., Joshi, G., Stanley, D., Kunchai, M., Eller, L., Bailer, R., Koup, R., Nabel, G., ,, Robb, M., and Ledgerwood, J., Safety and Immunogenicity of Ebola Virus and Marburg Virus Glycoprotein DNA Vaccines Assessed Separately and Concomitantly in Healthy Ugandan Adults: A Phase 1b, Randomised, Double-Blind, Placebo-Controlled Clinical Trial, Lancet, vol. 385, no. 9977, pp. 1545-1554, 2015.
W. Jaoko, Karita, E., Kayitenkore, K., Omosa-Manyonyi, G., Allen, S., Than, S., Adams, E., Graham, B., Koup, R., Bailer, R., Smith, C., Dally, L., Farah, B., Anzala, O., Muvunyi, C., Bizimana, J., Tarragona-Fiol, T., Bergin, P., Hayes, P., Ho, M., Loughran, K., and Komaroff, W., Safety and Immunogenicity Study of Multiclade HIV-1 Adeno-Viral Vector Vaccine Alone or as Boost Following a Multiclade HIV-1 DNA Vaccine in Africa, PLoS ONE, vol. 5, p. e12873, 2010.
L. Chang, Dowd, K., Mendoza, F., Saunders, J., Sitar, S., Plummer, S., Yamshchikov, G., Sarwar, U., Hu, Z., Enama, M., Bailer, R., Koup, R., Schwartz, R., Akahata, W., Nabel, G., Mascola, J., Pierson, T., Graham, B., and Ledgerwood, J., Safety and Tolerability of Chikungunya Virus-Like Particle Vaccine in Healthy Adults: A Phase 1 Dose-Escalation Trial, Lancet, vol. 384, no. 9959, pp. 2046-2052, 2014.
J. Casazza, Bowman, K., Adzaku, S., Smith, E., Enama, M., Bailer, R., Price, D., Gostick, E., Gordon, I., Ambrozak, D., Nason, M., Roederer, M., Andrews, C., Maldarelli, F., Wiegand, A., Kearney, M., Persaud, D., Ziemniak, C., Gottardo, R., Ledgerwood, J., Graham, B., and Koup, R., Therapeutic Vaccination Expands and Improves the Function of the HIV-Specific Memory T-Cell Repertoire, J Infect Dis, vol. 207, no. 207, pp. 1829-1840, 2013.